WAYNE, Pa.–(BUSINESS WIRE)–Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies with solutions in the fields of vascular and interventional access, surgical and cardiac care, will showcase the MANTA™ Vascular Closure Device as well as its portfolio for peripheral interventions at the Annual Meeting of the Leipzig Interventional […]
Other News
InspireMD’s CGuard™ Embolic Prevention System to be Prominently Featured in Live Case Transmissions at LINC, 22nd to the 25th January 2019, in Leipzig, Germany
TEL AVIV, Israel, Jan. 18, 2019 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE AMER:NSPR), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced that its CGuard™ Carotid Embolic Prevention System (EPS) will be featured in two live case transmissions at the Leipzig Interventional Course […]
Swiss Enrollment Begins for FLEX Vessel Preparation System: The BELONG Study
TOLEDO, Ohio, Jan. 17, 2019 /PRNewswire/ — VentureMed Group, Inc., a medical device company that develops and markets innovative interventional vascular solutions, announced enrollment of the first patients in the BELONG Study –BEnefit of arterial vessel preparation by LONGitudinal micro-incisions before drug eluting balloon angioplasty of the superficial femoral and popliteal arteries. The primary […]
HighLife Closes a €32 Million Round B Financing
PARIS–(BUSINESS WIRE)–HighLife SAS, a medtech company focused on the development of a unique transcatheter mitral valve replacement (“TMVR”) system to treat patients suffering from mitral regurgitation, announced today it had closed a €32 million round of equity financing. Proceeds from the financing will be used to complete the development of the company’s transcatheter transseptal […]
THE SAGE GROUP Announces Publication of U.S. Acute Limb Ischemia (ALI) Incidence and Market Estimates
BEAUFORT, S.C.–(BUSINESS WIRE)–A new analysis published by THE SAGE GROUP concludes that ALI represents a substantial market opportunity for pharmaceutical and interventional therapies. “Although the number of patients currently treated for an acute occlusion in the lower limbs is relatively small, the total market is surprisingly large,” stated Mary L. […]
Hemostemix Provides Highlights of 2018 Accomplishments
CALGARY, Alberta, Jan. 17, 2019 (GLOBE NEWSWIRE) — Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF) is pleased to provide the following corporate update on accomplishments and milestones that it has achieved in 2018. The past twelve months has seen a transformation in the Company, with a […]
Edwards Lifesciences To Host Earnings Conference Call on January 31, 2019
IRVINE, Calif., Jan. 17, 2019 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, plans to announce its operating results for the quarter ended December 31, 2018 after the market closes on Thursday, January 31, 2019, and will host a conference call at 5:00 p.m. ET that […]
Correvio Provides Update On At The Market Offering
VANCOUVER, Jan. 17, 2019 /PRNewswire/ – Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a revenue-generating, specialty pharmaceutical company focused on commercializing hospital drugs, today announced the completion of sales of all common shares qualified under its ATM Prospectus Supplement (defined below). The Company’s at-the-market sales issuance agreement, dated July 10, 2018, between the Company and […]
Itamar Medical to raise $12m with private placement
Itamar Medical (TASE:ITMR) said today that it stands to raise nearly $12 million in a private placement with American and Israeli investors. Caesarea, Israel-based Itamar, which makes sleep apnea and heart failure diagnostic devices, said the round consists of $8 million raised from Deerfield Management, Triple Gate Capital, West Elk Partners, and […]
Johnson & Johnson Announces Research Study with Apple Watch to Help Improve AFib Outcomes Including Stroke Prevention
New Brunswick, NJ, January 17, 2019 — Johnson & Johnson (NYSE: JNJ) today announced that Janssen Pharmaceuticals, Inc., member of the Johnson & Johnson Family of Companies, entered into a research study in collaboration with Apple Inc. to investigate whether a new heart health program using an app from Johnson […]
Recent
Popular
- No commented posts yet